We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

113 hedge funds and large institutions have $272M invested in Rigel Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 11

58% more capital invested

Capital invested by funds: $172M → $272M (+$99.6M)

18% more funds holding

Funds holding: 96 → 113 (+17)

17% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 30

8% more call options, than puts

Call options by funds: $193K | Put options by funds: $179K

Holders
113
Holders Change
+17
Holders Change %
+17.71%
% of All Funds
3.01%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
28
Increased
35
Reduced
30
Closed
11
Calls
$193K
Puts
$179K
Net Calls
+$14K
Net Calls Change
+$11K

Top Buyers

1
RPAM
Rhenman & Partners Asset Management
Sweden
+$2.74M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.42M
3
OAM
Oxford Asset Management
United Kingdom
+$1.28M
4
DCM
DAFNA Capital Management
California
+$989K
5
TI
Turner Investments
Pennsylvania
+$644K

Top Sellers

1
VAM
Visium Asset Management
New York
-$1.37M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.14M
3
BACM
Blue Arrow Capital Management
New York
-$1.02M
4
Norges Bank
Norges Bank
Norway
-$960K
5
BC
Broadfin Capital
New York
-$700K
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
76
New York State Common Retirement Fund
New York
$104K +$79.5K +2,900 New
SGAM
77
Smith Group Asset Management
Texas
$100K +$76.5K +2,790 New
AL
78
Airain Ltd
Guernsey
$97K -$62.9K -2,294 -46%
DTL
79
Dynamic Technology Lab
Singapore
$96K +$71.9K +2,621 New
AQR Capital Management
80
AQR Capital Management
Connecticut
$93K -$475K -17,310 -87%
EEG
81
E.E. Geduld
$89K +$68.5K +2,500 New
VKH
82
Virtu KCG Holdings
New York
$86K +$4.8K +175 +8%
CSS
83
Cubist Systematic Strategies
Connecticut
$79K +$60.8K +2,216 New
FSA
84
Franklin Street Advisors
North Carolina
$71K -$137K -5,000 -71%
PP
85
Paloma Partners
Connecticut
$69K -$109K -3,964 -67%
Allianz Asset Management
86
Allianz Asset Management
Germany
$68K +$52.1K +1,900 New
PNC Financial Services Group
87
PNC Financial Services Group
Pennsylvania
$64K – – –
TRCT
88
Tower Research Capital (TRC)
New York
$63K +$48.7K +1,775 New
Legal & General Group
89
Legal & General Group
United Kingdom
$62K – – –
ProShare Advisors
90
ProShare Advisors
Maryland
$60K -$4.14K -151 -8%
FANJ
91
Financial Architects (New Jersey)
New Jersey
$54K +$41.1K +1,500 New
Tudor Investment Corp
92
Tudor Investment Corp
Connecticut
$49K +$37.9K +1,381 New
GC
93
Guggenheim Capital
Illinois
$42K +$1.92K +70 +6%
HIM
94
Hillsdale Investment Management
Ontario, Canada
$42K +$32.4K +1,180 New
BFM
95
Boothbay Fund Management
New York
$41K +$31.1K +1,136 New
Wells Fargo
96
Wells Fargo
California
$40K +$18.4K +670 +151%
RCM
97
Rotella Capital Management
Washington
$38K +$29.5K +1,076 New
HighTower Advisors
98
HighTower Advisors
Illinois
$36K – – –
Creative Planning
99
Creative Planning
Kansas
$36K +$27.4K +1,000 New
Barclays
100
Barclays
United Kingdom
$29K -$28.7K -1,045 -52%
1 2 3
4
5

RIGL Hedge Fund Activity: Q1 2015 in Review

113 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q1 2015, worth a combined $272M — up 58% from $172M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new RIGL positions and 11 closed out — a net gain of 17 holders — while 35 added to existing stakes and 30 trimmed.

The largest buyer was Rhenman & Partners Asset Management, opening a new position worth an estimated $2.74M. The largest seller was Visium Asset Management, exiting entirely with an estimated $1.37M sold.

  • 113 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q1 2015, up from 96 in Q4 2014.
  • Funds reported $272M of Rigel Pharmaceuticals stock for Q1 2015, up 58% quarter-over-quarter.
  • 28 funds opened new Rigel Pharmaceuticals positions in Q1 2015 and 11 closed out, a net change of +17 holders.
  • The largest Rigel Pharmaceuticals buyer in Q1 2015 was Rhenman & Partners Asset Management, an estimated $2.74M added.
  • The largest Rigel Pharmaceuticals seller in Q1 2015 was Visium Asset Management, an estimated $1.37M sold.

Based on aggregated 13F filings for Q1 2015.